Genetic engineers and researchers alike have explicitly shared their affinity towards the gene-editing tool called CRISPR–Cas9. This device alters targeted genes effortlessly, thereby permitting an executable approach to developing treatments and cures. There is, however, a major limitation to Cas9 in terms of rectifying an isolated DNA letter in a gene. To address and remedy […]